Optimal cytoreductive surgery in patients with disseminated ovarian cancer (the department’s experience)

per N. G. Kormosh, K. P. Laktionov, A. N. Gritsai, N. S. Kerzhkovskaya
Publicat 2014-07-01

Adoptive immunotherapy with interleukin-2 and lymphokine-activated killers in patients with malignant neoplasms of the female reproductive system (a review of literature)

per A. N. Gritsai, D. A. Baranovsky, M. V. Kiselevsky, I. L. Gulyaeva
Publicat 2015-01-01

Ovarian sarcomas: a review of literature

per S. A. Shvachko, A. N. Gritsai, N. I. Lazareva, S. B. Peterson, A. V. Vasilevskaya
Publicat 2014-08-01

Management of ovarian carcinosarcomas (review of literature)

per A. N. Gritsai, S. A. Shvachko, N. I. Lazareva, S. B. Peterson, A. P. Nikolaev
Publicat 2014-07-01

Clinical and diagnostic value of the functional and conformational properties of serum albumin in patients with ovarian cancer (а pilot study)

per T. V. Davydova, I. I. Matveeva, A. N. Gritsai, N. R. Pogosyan, L. T. Mamedova, V. V. Kuznetsov
Publicat 2014-07-01

Intraperitoneal biotherapy of malignant peritoneal effusions in ovarian cancer patients

per К. S. Titov, A. N. Gritsai, L. V. Demidov, L. M. Rodionova, M. V. Kiselevsky, M. V. Mosina
Publicat 2014-07-01

INTRAPLEURAL IMMUNOTHERAPY FOR METASTATIC PLEURISIES IN PATIENTS WITH BREAST CANCER

per K. S. Titov, L. V. Demidov, M. V. Kiselevsky, I. N. Mikhailova, I. Zh. Shubina, A. N. Gritsai, I. E. Sinelnikov, L. M. Rodionova
Publicat 2014-09-01

High rate of mutations in the BRCA1, BRCA2, CHEK2, NBN, and BLM genes in Russian ovarian cancer patients

per Ye. I. Bateneva, M. G. Filippova, A. S. Tyulyandina, A. A. Meshcheryakov, K. I. Zhordania, A. N. Gritsai, V. V. Kadochnikova, D. D. Abramov, A. A. Ragimov, D. Yu. Trofimov, L. N. Lyubchenko
Publicat 2015-01-01